![[Updated] B-2 Spirit Bombers Struck Iranian Nuclear Sites](https://theaviationist.com/wp-content/uploads/2025/06/B2sGuam_2.jpg)
Lilly eyes global approval filings as once-weekly insulin candidate takes clinical victory lap
Lilly provided a comprehensive look at positive results from a group of studies that assessed the company's once-a-week insulin candidate efsitora in multiple Type 2 diabetes patient populations. Lilly says it plans to submit its efsitora package to global regulators by the end of the year.
Lilly provided a comprehensive look at positive results from a group of studies that assessed the company's once-a-week insulin candidate efsitora in multiple Type 2 diabetes patient populations. Lilly says it plans to submit its efsitora package to global regulators by the end of the year.
